Ablative Stereotactic Radiotherapy for Oligometastatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-Analysis
JAMA Oncol 2020 Nov 25;[EPub Ahead of Print], EJ Lehrer, R Singh, M Wang, VM Chinchilli, DM Trifiletti, P Ost, S Siva, MB Meng, L Tchelebi, NG ZaorskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.